316. Carnitine cycle disorder Clinical trials / Disease details

Clinical trials : 4 / Drugs : 10 - (DrugBank : 4) / Drug target genes : 2 - Drug target pathways : 11

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02226419 (ClinicalTrials.gov)	August 2013	5/8/2013	Fat and Sugar Metabolism During Exercise, With and Without L-carnitine in Patients With Carnitine Transporter Deficiency	Fat and Carbohydrate Metabolism During Exercise, With and Without L-carnitine Supplementation in Patients With Carnitine Transporter Deficiency	Carnitine Transporter, Plasma-membrane, Deficiency of	Dietary Supplement: Break in L-carnitine treatment	Karen Lindhardt Madsen	Rigshospitalet, Denmark	Completed	18 Years	N/A	Both	14	N/A	NULL
2	NCT00983788 (ClinicalTrials.gov)	October 2009	23/9/2009	Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects	Evaluation of the Effect of Bezafibrate on Muscle Metabolism During Exercise in Patients With CPTII and VLCAD Deficiency	Carnitine Palmitoyltransferase II Deficiency;Very Long Chain Acyl Coa Dehydrogenase Deficiency	Drug: Bezafibrate;Other: Placebo	Rigshospitalet, Denmark	Institut de Myologie, Pitié-Salpêtrière Hospital, France	Completed	18 Years	70 Years	Both	12	Phase 2	Denmark
3	NCT00336167 (ClinicalTrials.gov)	June 2006	9/6/2006	Bezafibrate Trial in CPT2 Deficiency	Clinical Trial on the Effect of Bezafibrate in the Muscular Form of Carnitine Palmitoyltransferase 2 Deficiency	Carnitine Palmitoyl Transferase 2 Deficiency	Drug: bezafibrate (drug)	Assistance Publique - Hôpitaux de Paris	Association Française contre les Myopathies (AFM), Paris;Institut National de la Santé Et de la Recherche Médicale, France	Recruiting	18 Years	N/A	Both	12	Phase 3	France